Nanomedicines: are we lost in translation?

International audience

<p>This special issue of the European Journal of Nanomedicine was set-up after the international meeting, which took place in Angers, France in August 2014. This meeting was entitled “translational nanomedicine”. In fact, the main question that was debated during the meeting was: how to better translate new nano-drug products to the market? Despite thousands of published research articles, there are today only just a few formulations that can be called nanomedicines, and that went through clinical phase III to become available to a large population. So, translation is really an issue that remains to be addressed. [...]</p>